Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagent
11 Mar 2008 -
Sigma-Aldrich, Oxford BioMedica and Open Biosystems, Inc. have jointly announced a confidential settlement of their patent litigation. Sigma-Aldrich and Oxford BioMedica agreed to dismiss the lawsuit brought against Open Biosystems. Open Biosystems agreed to dismiss its counterclaims in the lawsuit. As part of the settlement Open Biosystems will acquire certain license rights under the Oxford BioMedica
patents for use of the LentiVector technology in research activities. Other details of the agreement have not been disclosed.
Additional information
Sigma-Aldrich Corp. St. Louis, MO, United States of America
Top
Print version
PDF version
Send article
RSS feed